I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Nobuaki Matsubara
262
results:
Search for persons
X
Format
Online (262)
Mediatypes
Articles (Online) (165)
Bookchapter (Online) (2)
OpenAccess-fulltext (95)
Sorted by: Relevance
Sorted by: Year
?
1
Phase 3 THOR Japanese subgroup analysis: erdafitinib in adv..:
Matsubara, Nobuaki
;
Miura, Yuji
;
Nishiyama, Hiroyuki
...
International Journal of Clinical Oncology. , 2024
Link:
https://doi.org/10.1007/..
?
2
The TALAPRO-3 study design: a plain language summary:
Agarwal, Neeraj
;
Saad, Fred
;
Azad, Arun A.
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
3
Expert Consensus Recommendations on the Management of Treat..:
Shore, Neal D.
;
Broder, Michael S.
;
Barata, Pedro C.
...
European Urology Oncology. , 2024
Link:
https://doi.org/10.1016/..
?
4
Plain language summary of the results from the TALAPRO-2 st..:
Agarwal, Neeraj
;
Azad, Arun A
;
Carles, Joan
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
5
Genomic profiling and clinical utility of circulating tumor..:
Shiota, Masaki
;
Matsubara, Nobuaki
;
Kato, Taigo
...
BJC Reports. 2 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
6
Health-related Quality of Life in Patients with Previously ..:
Rosenberg, Jonathan E.
;
Mamtani, Ronac
;
Sonpavde, Guru P.
...
European Urology. 85 (2024) 6 - p. 574-585 , 2024
Link:
https://doi.org/10.1016/..
?
7
Japanese clinical practice guidelines for prostate cancer 2..:
Kohjimoto, Yasuo
;
Uemura, Hiroji
;
Yoshida, Masahiro
...
International Journal of Urology. , 2024
Link:
https://doi.org/10.1111/..
?
8
PD‐1 inhibition with retifanlimab and/or arginase inhibitio..:
Kuboki, Yasutoshi
;
Koyama, Takafumi
;
Matsubara, Nobuaki
...
Cancer Medicine. 13 (2024) 8 - p. , 2024
Link:
https://doi.org/10.1002/..
?
9
Pembrolizumab with or Without Lenvatinib as First-line Ther..:
Matsubara, Nobuaki
;
de Wit, Ronald
;
Balar, Arjun Vasant
...
European Urology. 85 (2024) 3 - p. 229-238 , 2024
Link:
https://doi.org/10.1016/..
?
10
Publisher Correction: First-line talazoparib with enzalutam..:
Fizazi, Karim
;
Azad, Arun A.
;
Matsubara, Nobuaki
...
Nature Medicine. 30 (2024) 5 - p. 1505-1505 , 2024
Link:
https://doi.org/10.1038/..
?
11
Safety and tolerability of long-term treatment with darolut..:
Jones, Robert Hugh
;
Fizazi, Karim
;
James, Nicholas D.
...
Prostate Cancer and Prostatic Diseases. , 2023
Link:
https://doi.org/10.1038/..
?
12
Safety Profile of Ipatasertib Plus Abiraterone vs Placebo P..:
Matsubara, Nobuaki
;
de Bono, Johann
;
Sweeney, Christopher
...
Clinical Genitourinary Cancer. 21 (2023) 2 - p. 230-237.e1 , 2023
Link:
https://doi.org/10.1016/..
?
13
The impact of the COVID‐19 pandemic on perioperative chemot..:
Baba, Kaede
;
Kawamoto, Megumi
;
Mamishin, Kanako
...
Cancer Medicine. 12 (2023) 11 - p. 12095-12105 , 2023
Link:
https://doi.org/10.1002/..
?
14
TALAPRO-3 Clinical Trial Protocol: Phase III Study of Talaz..:
Agarwal, Neeraj
;
Saad, Fred
;
Azad, Arun A
...
Future Oncology. 20 (2023) 9 - p. 493-505 , 2023
Link:
https://doi.org/10.2217/..
?
15
Prognostic value of immune phenotype and PD-L1 status in re..:
Tsuzuki, Toyonori
;
Ohe, Chisato
;
Osawa, Takahiro
...
Pathology. 55 (2023) 1 - p. 31-39 , 2023
Link:
https://doi.org/10.1016/..
1-15